Therefore, ascertaining the ability of T1AM, and endogenous agonist for TAAR1 will lead to a better understanding of the role of TAAR1 as a modulator of microglia dysregulation, further expanding the potential of drugs that interact with TAAR1 in the management of AD. This evidence concerns the gene TAAR1 and Alzheimer disease.